Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis

Urology

Volumn 64, Issue 3, 2004, Pages 598-602

  Schultheiss, Dirk ^a,b   Pilatz, Adrian ^a   Gabouev, Alexander I ^a   Schlote, Norbert ^a   Wefer, Jörg ^a   Mertsching, Heike ^b   Sohn, Michael ^c   Jonas, Udo ^a   Stief, Christian G ^a  

^a Dept of Urol and Pediatric Urology ^*  (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c AGAPLESION MARKUS KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; SODIUM CHLORIDE; TETRAZOLIUM; VASOACTIVE AGENT;

ADULT; ARTICLE; CELL COUNT; CELL CULTURE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; CYTOTOXICITY; DOSE RESPONSE; DRUG EXPOSURE; ENDOTHELIUM CELL; ENZYME RELEASE; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MEASUREMENT; METABOLISM; PENIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOOTH MUSCLE; STAINING; STROMA;

ALPROSTADIL; CELL DEATH; CELLS, CULTURED; DRUG INTERACTIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROGEN-ION CONCENTRATION; IMPOTENCE; L-LACTATE DEHYDROGENASE; MALE; PAPAVERINE; PENIS; PHENTOLAMINE; VASODILATOR AGENTS;

EID: 4444348172     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.04.034     Document Type: Article

References (31)

1. Montorsi F., Althof S.E., Sweeney M., et al. Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(1) intracavernosal injection therapy to oral sildenafil citrate. Int J Impot Res. 15:2003;444-449
2. Montorsi F., Salonia A., Zanoni M., et al. Current status of local penile therapy. Int J Impot Res. 14:(suppl 1):2002;S70-S81
3. 1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses. J Urol. 155:1996;913-914
4. Govier F.E., McClure R.D., Weissman R.M., et al. Experience with triple-drug therapy in a pharmacological erection program. J Urol. 150:1993;1822-1824
5. 1 with other intracavernous injections. Eur Urol. 26:1994;319-321
6. McMahon C.G., Samali R., Johnson H. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol. 162:1999;1992-1998
7. Steers W.D. Viability and safety of combination drug therapies for erectile dysfunction. J Urol. 170:2003;S20-S23
8. 1 injection therapy a follow-up of 44 patients. Int J Impot Res. 15:2003;94-98
9. 1 in erectile failure a survey of worldwide experience. J Urol. 155:1996;802-815
10. 1, and saline in primates. J Urol. 142:1989;403-408
11. Abozeid M., Juenemann K.P., Luo J.A., et al. Chronic papaverine treatment the effect of repeated injections on the simian erectile response and penile tissue. J Urol. 138:1987;1263-1266
12. Hwang T.I., Yang C.R., Ho W.L., et al. Histopathological change of corpora cavernosa after long-term intracavernous injection. Eur Urol. 20:1991;301-306
13. Sahin M., Basar M.M., Bozdogan O., et al. Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil an experimental study. Urology. 58:2001;487-492
14. Stackl W., Loupal G., Holzmann A. Intracavernous injection of vasoactive drugs in the rabbit. Urol Res. 16:1988;455-458
15. 1 therapy modify the intracavernous musculature? J Urol. 163:2000;464-466
16. Bivalacqua T.J., Usta M.F., Champion H.C., et al. Endothelial dysfunction in erectile dysfunction role of the endothelium in erectile physiology and disease. J Androl. 24:2003;S17-S37
17. Schultheiss D., Badalyan R., Pilatz A., et al. Androgen and estrogen receptors in the human corpus cavernosum penis immunohistochemical and cell culture results. World J Urol. 21:2003;320-324
18. van Ahlen H., Peskar B.A., Sticht G., et al. Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. J Urol. 151:1994;1227-1230
19. Rajasekaran M., Pagnon V., Monga M. Vasoactive agents induce cytotoxicity in cultured human penile smooth muscle cells. Urology. 59:2002;155-158
20. da Costa A.O., de Assis M.C., Marques Ede A., et al. Comparative analysis of three methods to assess viability of mammalian cells in culture. Biocell. 23:1999;65-72
21. Kato M., Makino S., Kimura H., et al. Evaluation of mitochondrial function and membrane integrity by dual fluorescent staining for assessment of sperm status in rats. J Toxicol Sci. 27:2002;11-18
22. Cummings B.S., Zangar R.C., Novak R.F., et al. Cytotoxicity of trichloroethylene and S-(1, 2-dichlorovinyl)-L-cysteine in primary cultures of rat renal proximal tubular and distal tubular cells. Toxicology. 150:2000;83-98
23. Granchi S., Vannelli G.B., Vignozzi L., et al. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. Mol Hum Reprod. 8:2002;1053-1064
24. van Ahlen H., Piechota H.J., Hermanns M., et al. Metabolic changes in the human corpus cavernosum under vasoactive substances. Int J Impot Res. 2:(suppl 2):1990;244
25. 1 for pharmacologic erection. J Urol. 141:1989;1458-1459
26. Stackl W., Stief C.G., Benard F., et al. Intracavernous injection of solutions with different osmolarity and pH in the rabbit. Int J Impot Res. 1:1989;197-200
27. Gao Y.J., Stead S., Lee R.M. Papaverine induces apoptosis in vascular endothelial and smooth muscle cells. Life Sci. 70:2002;2675-2685
28. Brown S.L., Haas C.A., Koehler M., et al. Hepatotoxicity related to intracavernous pharmacotherapy with papaverine. Urology. 52:1998;844-847
29. Cooper G.J., Gillot T., Parry E.A., et al. Papaverine injures the endothelium of the internal mammary artery. Cardiovasc Surg. 3:1995;553-555
30. Gao Y.J., Yang H., Teoh K., et al. Detrimental effects of papaverine on the human internal thoracic artery. J Thorac Cardiovasc Surg. 126:2003;179-185
31. Vick R.N., Benevides M., Patel M., et al. The efficacy, safety and tolerability of intracavernous PNU-83757 for the treatment of erectile dysfunction. J Urol. 167:2002;2618-2623